Skip to main content
Tags: joe biden | bernie sanders | novo | nordisk | eli lilly | weight | loss

Biden to Novo Nordisk, Lilly: Cut Weight-Loss Drug Prices

Biden to Novo Nordisk, Lilly: Cut Weight-Loss Drug Prices
President Joe Biden with Senator Bernie Sanders, D-Vermont, after delivering remarks on lowering health care costs at the White House in Washington, April 3, 2024. (Yuri Gripas/AP)

Tuesday, 02 July 2024 09:04 AM EDT

U.S. President Joe Biden and Senator Bernie Sanders called on Novo Nordisk and Eli Lilly to reduce the prices of their weight loss and diabetes drugs, in an opinion piece by them published in USA Today Tuesday.

A 2 milligram package of Ozempic carries a list price of $935.77 in the U.S., while Wegovy is priced at $1,349.02 per package, according to the drugmaker's website. Eli Lilly's Mounjaro costs roughly $1,100 per month.

"If the prices of these drugs are not substantially reduced, they have the potential to bankrupt the American health care system," they said. "Novo Nordisk must substantially reduce the price of Ozempic and Wegovy."

Novo and Eli Lilly did not immediately respond to Reuters requests for comment. Shares of the Danish drugmaker fell more than 1.5%, while rival Eli Lilly fell 2% in U.S. premarket trading.

High U.S. prescription drug prices have long been under the scrutiny of lawmakers on both side of the aisle. Biden, a Democrat, has made lowering healthcare costs a key part of his 2024 re-election campaign.

Sanders, as chairman of the U.S. Senate's health committee, has already taken a series of actions - from sending letters to holding hearings - aimed at pressuring the pharmaceutical industry to lower costs.

He sent a letter in April to Novo President Doug Langa seeking more information on U.S. prices for Ozempic and Wegovy.

As millions seek access to weight-loss drugs from Novo Nordisk and Lilly, increasing supplies, possible wider usage and a growing number of would-be rivals are leading some experts to raise annual global sales forecasts for the treatments to about $150 billion by the early 2030s.

The Biden administration has initiated price negotiations on a list of 10 high-cost drugs for the U.S. Medicare program, which currently does not include weight loss drugs.

© 2024 Thomson/Reuters. All rights reserved.


Newsfront
U.S. President Joe Biden and Senator Bernie Sanders called on Novo Nordisk and Eli Lilly to reduce the prices of their weight loss and diabetes drugs, in an opinion piece by them published in USA Today Tuesday.
joe biden, bernie sanders, novo, nordisk, eli lilly, weight, loss, prices
300
2024-04-02
Tuesday, 02 July 2024 09:04 AM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
TOP

Interest-Based Advertising | Do not sell or share my personal information

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved
Download the NewsmaxTV App
Get the NewsmaxTV App for iOS Get the NewsmaxTV App for Android Scan QR code to get the NewsmaxTV App
NEWSMAX.COM
America's News Page
© Newsmax Media, Inc.
All Rights Reserved